Pharmaceuticals News and Research

RSS

Brain cell activity influences formation of brain plaque ingredient

Increased communication between brain cells increases levels of amyloid beta, the key ingredient in Alzheimer's brain plaques, scientists at Washington University School of Medicine in St. Louis have found.

22 Dec 2005

Cannabis medication linked to grandmother's death

A British grandmother who died after being given a controversial and experimental cannabis-based medicine had apparently told her family that she thought the drug was driving her mad.

19 Dec 2005

Groundbreaking research into some of the most deadly antibiotic-resistant diseases

Pioneering research by a North East of England scientist could lead to a cure for some of the most deadly antibiotic-resistant diseases.

15 Dec 2005

University at Buffalo researches rules for targeting RNA

Once described as DNA's less-famous chemical cousin, RNA, or ribonucleic acid, recently has moved to center stage.

15 Dec 2005

Microfluidics chips for simplifying medical imaging biomarkers of disease

A collaboration between scientists at UCLA, Caltech, Stanford, Siemens and Fluidigm have developed a new technology using integrated microfluidics chips for simplifying, lowering the cost and diversifying the types of molecules used to image the biology of disease with the medical imaging technology, Positron Emission Tomography (PET).

15 Dec 2005

Canada's first prescription drug atlas maps billions in spending

Researchers at the University of British Columbia Centre for Health Services and Policy Research have developed a comprehensive portrait of pharmaceutical spending in Canada -- more than $20 billion by the end of 2005 -- and assembled the results into a first-of-its-kind atlas.

15 Dec 2005

Companies warned about shonky bird flu remedies

The appearance of so-called bird flu remedies which have hit the market in the U.S. have prompted the Food and Drug Administration (FDA) to issue warnings to nine companies.

14 Dec 2005

Gene mapping project promises new targeted cancer therapies

Government researchers in the United States have this week launched a pilot project to find all the little genetic changes that cause cancer in the hope it will lead to a whole new world of targeted cancer therapy.

14 Dec 2005

MorphoSys signs agreement with Merck

MorphoSys AG announced today that it has signed a five-year license agreement with U.S. pharmaceutical company Merck & Co., Inc. for the use of MorphoSys’s HuCAL GOLD and AutoCAL technologies in research and development of human therapeutic antibodies.

14 Dec 2005

Testosterone replacement therapy shows promise for Alzheimer sufferers

The first study of the effects of testosterone on mood, behavior and psychological health in men with mild Alzheimer disease finds significant improvements in quality of life, as assessed by caregivers.

13 Dec 2005

AMN107 drug shows promise in leukemia resistance to Gleevec

The targeted agent AMN107 can produce dramatic benefits in patients with some forms of leukemia that are resistant to Gleevec, the standard therapy for these cancers, say researchers at The University of Texas M. D. Anderson Cancer Center.

13 Dec 2005

Roche chooses partners to help make Tamiflu

The producer of sought after bird flu drug Tamiflu, drug giant Roche, has apparently chosen 12 possible partners to help it churn out enough of the drug.

12 Dec 2005

Is the FDA too influenced by big pharma?

The U.S. Food and Drug Administration's (FDA) historically sound reputation could be in jeopardy due to it's possibly too close relationship with the major pharmaceutical companies.

12 Dec 2005

Buttock injections do not provide proper dose

Women may not be getting the most out of vaccines and other injections, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).

7 Dec 2005

New anti-clotting treatment

Volunteers at the Jack and Linda Gill Heart Institute at the University of Kentucky were the first ever to receive a new anti-clotting therapy.

7 Dec 2005

Physicians slow to prescribe newer heart drugs

An analysis of the treatment received by more than 100,000 heart patients has shown that physicians' prescription practices for drugs proven effective for treating heart disease has shown steady improvement over the past three years, cardiologists at the Duke Clinical Research Institute (DCRI) have concluded.

7 Dec 2005

Pricey head lice treatment nothing but common cleanser

An expensive experimental head lice treatment for children has been revealed as nothing more than a common skin cleanser costing as little as $10 a bottle.

5 Dec 2005

Findings may help in development of new anti-inflammatory compounds

Virginia Commonwealth University researchers studying the enzyme that triggers inflammation have found that it may be a target for a new class of anti-inflammatory drugs to treat arthritis, asthma, multiple sclerosis, lung and colon cancers and Alzheimer's disease.

2 Dec 2005

Herceptin - can healthcare afford this expensive drug?

New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.

2 Dec 2005

New anthrax antibody

A new anthrax antibody engineered by scientists at The University of Texas at Austin protects and defends against inhalation anthrax without the use of antibiotics and other more expensive antibodies.

2 Dec 2005